Why the Alphabet Stock Looks Like a Golden Buy Opportunity
A recent talent exodus rattled Alphabet, but the long-term AI moat, cloud momentum, and strong cash flow argue for pa...
This analysis highlights how long-term returns vary across index funds, emphasizing the impact on portfolio resilience.
28,357 articlesA recent talent exodus rattled Alphabet, but the long-term AI moat, cloud momentum, and strong cash flow argue for pa...
RFK Jr. floated a plan to raise payroll taxes by about one-third to close Social Security's funding gap, a move that ...
OpenAI will stagger the rollout of its top AI model, requiring government clearance for initial access. The move coul...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
On his nationally syndicated show, Dave Ramsey counseled a 21-year-old father of two to settle his debt now and rebui...
A broad study shows younger adults delaying key life events, pressuring insurers to rethink offerings as 'living bene...
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
A prominent hedge fund just sold its entire XPeng stake, triggering questions for everyday investors. Learn how to ev...
As Netflix stumbles, investors wonder if Disney down 2026 offers a rare contrarian opportunity. This article digs int...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
In 2024, medicare paid $12.3 billion for a cluster of services that are now facing tighter coverage. This shift could...
A notable new stake in Kyndryl signals growing confidence from a private equity–style shop. This deep dive explains w...